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To determine the prevalence of wheat sensitivity in a randomly selected Australian popula-
tion, a study was carried out on sera samples of the Geelong Osteoporosis Study (GOS)
age-stratified cohorts of men and women who were randomly selected from electoral rolls for
the Barwon Statistical Division (n = 1145). The human sera were analysed by ELISA-based
method using the ImmunoCAP 100 instrument (Phadia, Sweden). IgE from human sera were
bound to the wheat (f4) and milk (f2) allergens that have been previously coated on the
ImmunoCAPs. The number of IgE wheat and milk RAST positive individuals was deter-
mined. In order to relate the increased IgE immuno-reactivity to allergen symptoms, a ques-
tionnaire was established and sent to the blood donors and 974 individuals responded. Of these
(n = 974) 147 individuals (15.1%) reported symptoms caused by wheat consumption, 179
(15.6%) and 112 (9.8%) sera showed RAST positive results (IgE > 60 response units) in wheat
and milk RAST tests, respectively. However, only 2.5% of those participants with symptoms
related to wheat had positive IgE values indicating that the relationship is complex: a large
proportion (12.7%) of the investigated population might suffer from other wheat related disor-
ders (i.e. not IgE mediated), such as celiac disease, non-celiac reaction to gluten, reaction to
fructans for those with irritable bowel syndrome as well as other factors. For the 13.2% who
showed raised IgE antibody levels without symptoms we postulate that these individuals have
latent wheat sensitivity with the potential of developing symptoms sooner or later.
A comparative study to investigate the immune reactivity of human IgE against wheat and
spelt antigens was carried out using the sera of 73 patients found to be RAST positive for
wheat. Of these 63% (n = 50) showed a higher IgE immune reactivity against wheat, while
30% (n = 24) showed higher IgE response against spelt antigens, the remaining 7% have indif-
ferent responses against both antigens. Since the provided Phadia wheat and spelt antigens
used in this study originated from Europe, Australian wheat and spelt varieties were also used
to prepare antigens in order to investigate the response of Australian sera to local wheats. It
was found that the immune reactivity of IgE wheat positive sera from a normal Australian pop-
ulation is lower for spelts compared to wheats regardless of their origin but much lower against
an Australian spelt containing a mutation in its expansin gene. A clinical feeding trial would be
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necessary to confirm if this difference in immune reactivity between spelt and wheat is consis-
tent with a difference in allergenicity.
Keywords: wheat related health disorders, prevalence of wheat sensitivity, IgE RAST test,
expansin
Introduction
There remains uncertainty regarding the prevalence of food allergy, particularly to fruits,
vegetables, nuts, and other edible plants. Although diagnostic studies have objectively
verified allergic reactions caused by ingestion of plant food, the extent of the problem on
the population level remains unclear for patients and their families, schools, the catering
industry, food producers and retailers, health professionals, and policy makers (Zuidmeer
et al. 2008).
Consumption of “gluten”-containing food causes a significant disease for a minority
group of people who consume foods derived from wheat, rye, barley and oats. Commer-
cial activity related to “gluten toxicity” and “wheat allergy” is largely focused upon “glu-
ten-free” food. The fact is, however, that in several types of diseases related to the con-
sumption of “gluten”-containing cereals, the trigger compounds are not components of the
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Figure 1. Spectrum of gluten related disorders (based on Sapone et al. 2012)
gluten. There is a lack of related knowledge about the causes of different symptoms or dis-
eases and about the terms “gluten”, “prolamins”, “gliadin”, “glutenin” not only in the
minds of the consumer but also in medical practice (Islam et al. 2011).
The spectrum of “gluten”-related disorders can be divided into three main groups: auto-
immune, allergic and not autoimmune allergic disorders (Sapone et al. 2012) (Fig. 1). Two
of these disorder types, the autoimmune and the allergic disorders are relatively well de-
scribed, however, further studies are needed to reveal mechanisms related to the diverse
symptoms of allergic reactions. The autoimmune disorders include celiac disease (Ander-
son and Wieser 2006) gluten athaxia and dermatitis herpetiformis (Laurière et al. 2006).
The allergic reactions involve respiratory allergy (Amano et al. 1998), food allergy (Mills
et al. 2004), wheat-dependent exercise induced anaphylaxis (Armentia et al. 1990) and
contact urticaria. Symptoms of celiac disease are triggered by an abnormal response of
auto-antibodies, such as antibodies to tissue-transglutaminase, or antibodies against
proline- and glutamine-rich wheat gluten proteins or their barley and rye homologs (Green
and Cellier 2007). Celiac disease shows strong association with HLA-DQ alleles and car-
riage of certain HLA-DQ molecules is the most important genetic factor to develop detri-
mental symptoms (Sollid et al. 2012). HLA-DQ heterodimers function as surface type re-
ceptor proteins bound to the surface of the antigen presenting cells. The presence of
HLA-DQ molecules such as DQ 2.5, DQ 8, DQ 2.2 is known as a clear marker for devel-
oping autoimmune symptoms, with modifying effects coming from genetic and environ-
mental factors (Anderson et al. 2000). The different serotypes recognize different pep-
tides. A set of criteria can be defined for the structure of an active CD epitope: a) the size of
nine amino acids, b) the presence of a tissue transglutaminase 2 (tTG) enzyme binding
site, c) surrounded by amino acids with defined charge and hydrophobicity (Sollid et al.
2012). Patients suffering from celiac disease produce a range of autoimmune responses to
several alpha-gliadin, LMW glutenin and gamma-gliadin peptides in the consumed wheat
products.
The development of wheat allergies is mediated more directly by the recognition of al-
lergens by specific IgE epitopes bound to mast cells (Catassi and Fasano 2008). Depend-
ing on the route of the wheat allergen exposure, symptoms can be divided into symptoms
of classic food-allergy; wheat-dependent exercise-induced anaphylaxis (WDEAI); occu-
pational asthma and urticaria (Sapone et al. 2012). Classic food allergy symptoms may af-
fect to the skin, gastrointestinal or respiratory tract. While atopic dermatitis is mainly char-
acteristic on children, WDEIA or urticaria were mostly identified in adults. Bakers’
asthma, one of the most prevalent respiratory allergies, is a significant symptom among
adults working with wheat flour. In wheat allergy, allergen presenting B-cells and T-cells
has the same level of impact and, similar to other food allergies, allergic reactions are the
result of special cross-links between specific immunoglobulin E and short peptides rich in
glutamine and proline that result from the breakdown of wheat seed proteins by endoge-
nous proteases (Sapone et al. 2012). This interaction stimulates basophils and mast cells to
release chemical mediators, such as histamines resulting in different categories of inflam-
matory reactions. The allergenic regions of protein recognized by the binding sites of IgE
molecules are called IgE-binding epitopes. These epitopes can be classified into two cate-
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gories, conformational and linear epitopes and both types are involved in the development
of allergic reactions (Akagawa et al. 2007).
The general public in most Western countries is now aware of cereal products that are
“high GI” and contain “allergenic” gluten from frequent articles in the media as well as a
number of popular books (Braly and Hogganm 2002; Ford 2008; Wangen 2009; Davis
2011), promoting gluten-free diets, many without drawing attention to the importance of
appropriate diagnosis or defining what gluten “intolerance” an individual may have. Such
adverse publicity poses a significant threat to the grain industry.
There is a considerable variation in the levels of wheat allergy reported in the literature.
In the past decade the prevalence of sensitivity to wheat among children and adult patients
has been reported to have increased to levels of approximately 15%–20% of the human
population, presenting a major health problem in industrial countries (Hischenhuber et al.
2006). Celiac disease primarily affects the Caucasian population of countries where
wheat, rye, and/or barley are important nutrients (Corazza and Gasbarrini 1995). Gluten
sensitive disease is uncommon in Africa, as well as only rare cases were identified from
Eastern and Southern Asia. About 15–20 years ago, the reported cumulative incidence
rate of celiac disease in Europe was widely different ranging between 1:400–1:12800
births; however, with the development of diagnostic tools the reported prevalence rates
have reached the 1:100–1:300 in the European countries (Greco et al. 1992; Anderson and
Wieser 2006).
Clinical symptoms of wheat allergy are often similar to those of celiac disease (urti-
caria, atopic dermatitis, nausea, vomiting, diarrhoea, rhinitis, anaphylaxis, etc.). However,
their pathogenic mechanisms are different, therefore their differentiation, diagnosis and
treatment can be challenging. The diagnosis of food allergy to wheat is often not well pre-
dicted by the increased level of serum specific IgE caused by wheat consumption
(Ortolani and Pastorello 2006). The true prevalence of food allergy is difficult to establish;
however, research indicates the incidence is increasing in the population. The prevalence
of wheat sensitization in a population based on specific IgE investigated in several Euro-
pean countries indicated slightly higher perception of allergic reaction than that of sensiti-
zation assessed by skin prick test (Rona et al. 2007).
The growing number of wheat related food disorders draws attention to this serious
health concern. In addition to the obvious detrimental effects of health and daily diet, there
are potentially long-term medical, psychological, and social effects. Correctly diagnosing
wheat and gluten related disorders is often challenging, especially given the limitations of
current diagnostic testing. However, it is important to prevent children from unnecessary
invasive treatments and potentially unhealthy dietary restrictions. Therefore, research is
needed to determine the precise prevalence of different wheat and gluten related disorders,
to discover more accurate and less invasive procedures for identification of the mecha-
nisms that lead to adverse reactions against wheat and related cereals and find suitable
source materials with low or no allergenic effects.
The two aims of this study were to determine of the prevalence of wheat sensitization in
a large randomly selected Australian population for specific IgE and to compare the im-
mune reactivity of wheat and a novel spelt line based on its soluble protein composition.
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Materials and Methods
Sera sample selection
A large set of blood samples from randomly selected individuals (n = 1145) was obtained
from the Geelong Osteoporosis Study (GOS), Geelong, Victoria, Australia. Serum sam-
ples of the GOS age-stratified cohorts of men (n = 1540 in 2001–2006) and women (n =
1494 in 1994–1997 and n = 221 in 2006–2008) that were randomly selected from the elec-
toral rolls of the Barwon Statistical Division. In 2009–2010, participants were invited to
participate in this sub-study (Pasco et al. 2012). From a group of 2075 potential partici-
pants, 1145 provided blood samples for the analyses of IgE against wheat and milk anti-
gens. All participants provided written consent and the study was approved by the Barwon
Health Human Research Ethics Committee, Australia.
Determination of IgE levels by Phadia ImmunoCAP 100
The human sera were analysed by ELISA-based method using the ImmunoCAP 100 in-
strument (Phadia, Sweden). IgE from human sera were bound to the wheat (f4) and milk
(f2) allergens that have been previously coated on the ImmunoCAPs. Bound IgE were
captured by the anti-IgE conjugate and the conjugate enzyme reacts with the flourogenic
substrate to form a fluorescent product (Johansson 2004). Reactivity was detected as re-
sponse units and IgE concentration (kU/L) was calculated from the standard curve.
A subset of individuals (n = 73) with positive reactivity against wheat (f4) from the
GOS cohort (Pasco et al. 2012) were selected and further analysed for IgE against spelt an-
tigen (f124) using the ImmunoCAP 100 (Phadia, Sweden). Six individuals with low sensi-
tivity to wheat (3 low in milk, 3 high in milk) were also selected as negative controls.
A similar assay was also developed (adapting the method of Erwin et al. 2005) in order
to compare the reaction of the above subset of 73 individuals, having raised IgE to wheat,
against in-house prepared antigens from Australian wheat and spelt (GWF spelt). The
analysis of the Australian derived antigens was optimized by coupling the soluble antigens
with streptavidin beads and assayed using the Phadia ImmunoCAP 100 machine.
Coupling of wheat and spelt antigens to streptavidin caps
Grains of wheat cultivar Kukri and a spelt line (GWF spelt) with unusual soluble protein
composition (Vu 2014) were milled and soluble proteins were extracted according to the
modified method of Osborne protocol (Scholz et al. 2000). The concentrations of the wa-
ter soluble proteins were determined by the bicinchoninic acid (BCA) protein assay kit
(Pierce). Purified antigens were biotinylated according to the Pierce EZ-Link® Biotinyla-
tion Kit (Thermo Fisher). The streptavidin caps have been pre-washed and the bio-
tinylated antigens were added.
Survey for symptoms associated with food consumption
Food allergy questionnaires were provided by Barwon Health (Victoria, Australia) to the
GOS participants and statistical analyses were conducted to establish relationships be-
Cereal Research Communications 43, 2015
VU et al.: The Prevalence of Wheat and Spelt Sensitivity 101
tween individuals with clinical symptoms and immune-responses. The population has
been divided into four subgroups: a) real positives where positive immune-responses cor-
responded with clinical symptoms, b) real negatives with no immune-response and no re-
ported clinical symptoms, c) false positives where immune-response has been detected
without clinical symptoms and d) false negatives no immune responses were found while
clinical symptoms have been reported.
Results
IgE responses against wheat (f4) and milk (f2) in the GOS cohort
Based on the IgE cut-off of 60 response unit (equivalent to 0.1 kU/L) (Phadia, Sweden),
14.1% (162 individuals) and 8.4% (96 individuals) of the population showed raised IgE
antibody levels against wheat and milk, respectively (Table 1). From the 14.1% raised IgE
levels against wheat antigen, 2.6% (n = 30) are considered to be wheat allergic class 1
(IgE: 0.35–0.70 kU/L), 2.3% (n = 27) in class 2 (IgE: 0.71–3.50 kU/L) and 1.0% (n = 11)
in class 3 (IgE: 3.51–17.50 kU/L). The remaining 8.2% (n = 94) with IgE between
0.10–0.35 kU/L may be considered as low level and have the possibility of developing
sensitisation to wheat later in life.
For milk we found 0.9% (n = 10) are class 1, 1.4% (n = 16) are class 2 (IgE: 0.71–3.50
kU/L) and 0.1% (n = 1) are class 3; while 6.0% (n = 69) have IgE levels between 0.10–0.35
kU/L. The prevalence of milk allergy based on serum IgE assessment ranges from 2% to
9% in European countries (Rona et al. 2007). In Australia, based on the GOS cohort, we
found that 2.4% of the randomly selected population are sensitized to milk (IgE cut-off
0.35 kU/L), while the remaining 6.0% with raised IgE (>0.10 kU/L) have the possibility of
developing sensitization later on in life.
Prevalence of wheat sensitivity in a randomly selected Australian population
In order to relate the increased IgE immune-reactivity to allergen symptoms, a set of ques-
tionnaires was established and sent to the blood donors; 974 individuals responded. Based
on the questionnaires for conditions associated with food types and the intensity ranging
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Table 1. IgE responses against wheat (f4) and milk (f2) in the GOS cohort
Wheat (f4) Milk (f2)
IgE>0.1 kU/L (60 RU) n = 162 (14.1%) IgE>0.1 kU/L (60 RU) n = 96 (8.4%)
Allergic Class (kU/L) No. % Allergic Class (kU/L) No. %
Class 0 (0.10–0.35) 94 8.2 Class 0 (0.10–0.35) 69 6.0
Class 1 (0.35–0.70) 30 2.6 Class 1 (0.35–0.70) 10 0.9
Class 2 (0.71–3.50) 27 2.3 Class 2 (0.71–3.50) 16 1.4
Class 3 (3.50–17.50) 11 1.0 Class 3 (3.50–17.50) 1 0.1
IgE<0.1 kU/L (60 RU) n = 983 (85.9%) IgE<0.1 kU/L (60 RU) n = 1049 (91.6%)
from none to strong severity, 15.3% (n = 149) reported symptoms caused by wheat con-
sumption and 11.7% (n = 114) experienced symptoms with milk (Table 2).
Results from ImmunoCAP 100 IgE and questionnaires were superimposed to correlate
the prevalence of raised IgE against wheat antigen and symptoms associated with con-
sumption of wheat. From the 974 responses, 15.3% (n = 149) have raised IgE > 0.10 kU/L,
while 84.7% (n = 825) have IgE < 0.10 kU/L. From the 15.3% of raised IgE individuals,
only 2.5% (n = 24) have reported symptoms, while 12.8% (n = 125) have no symptoms as-
sociated with consumption of wheat-based products. On the other hand, 12.9% (n = 126)
of the low IgE levels (IgE < 0.10 kU/L) reported symptoms associated with ingestion of
wheat, while 71.8% (n = 699) have no reactions.
IgE responses against wheat (f4) and spelt (f124)
Individuals (n = 73) with cut off IgE > 60 response unit (RU) (equivalent 0.10 kU/L)
against wheat antigen (f4) were further analysed for IgE against spelt antigen (f124) and 6
individuals with IgE < 60 RU were selected as negative controls.
Each of the 73 sera in this selected group showed higher immune-response to wheat
than the cut off value of 60, while only 64 individuals have IgE > 60 RU against spelt anti-
gen (Fig. 2). 49% (n = 39) of the individuals sera showed greater IgE response against
wheat than spelt, where 39% (n = 31) of these individuals sera have IgE > 60 RU against
spelt. In contrast, 29% (n = 23) are more responsive to spelt than wheat; and 22% (n = 17;
where 6 are negative controls and 11 sera have IgE > 60 RU) have similar response against
both antigens.
Immunoreactivity of GWF spelt
Since the commercial wheat and spelt antigens used in the Phadia assay system originated
from Europe, a commercial bread wheat cultivar, Kukri and a spelt line (GWF spelt) with
unusual soluble protein composition (Vu 2014) have been selected to examine the differ-
ences from an Australian consumer perspective and from the point of view of soluble pro-
tein composition. The comparison between commercial antigens and coupled soluble pro-
teins from the Australian wheat and GWF spelt showed good correlations where r2 = 0.92
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Table 2. Prevalence of wheat and milk sensitivity in a randomly selected Australian population: Raised IgE
against wheat and milk antigen and reported symptoms associated with consumption of wheat and milk
Symptoms
Yes No
N (%) N (%) N (%)
Wheat n 976 (100.00) 149 (15.27) 825 (84.53)
IgE > 60 149 (15.27) 24 (2.46) 125 (12.81)
IgE£ 60 827 (84.73) 126 (12.91) 699 (71.62)
Milk n 974 (100.00) 114 (11.70) 860 (88.30)
IgE > 60 164 (16.40) 14 (1.44) 122 (12.53)
IgE£ 60 824 (84.60) 86 (8.83) 738 (75.77)
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Figure 2. IgE response against wheat (f4) and spelt (f124) antigens
Figure 3. Differences in IgE response between wheat (f4) and GWF spelt in the selected group of individuals
(n = 17)
(n = 23) (n = 39)
(n = 4) (n = 75)
–1000 –500 500 1000
500 1000–1000 –500
for wheat and r2 = 0.88 for spelt, respectively, allowing conversion of the data derived us-
ing the coupled streptavidin antigens to those using commercial antigens.
Using these relationships, the streptavidin coupled antigen data (GWF spelt) has been
normalized to compare with the commercial Phadia wheat (f4) antigens (clinical bench-
mark). The IgE response against wheat (f4) was found to be significantly higher (95% of
the sera; n = 75) than GWF spelt, and only 41 of these individuals (55%) have IgE > 60 RU
against GWF spelt (Fig. 3). Four individuals showed higher IgE response against the
GWF spelt than wheat but they are at a much lower intensity as compared to the Phadia an-
tigens. This suggests GWF spelt elicits a significantly lower immune-response compared
with the Phadia commercial spelt antigen (Fig. 2), where only 57% of sera had IgE > 60
RU against GWF spelt as compared to 82% against the Phadia spelt antigen.
Discussion
Results shown in Table 2 indicate that in Australia the prevalence of wheat allergy in a
randomly selected population is 2.5% where both positive IgE immune response and
symptoms against wheat were observed. These results are in full agreement with similar
investigations on wheat where the prevalence of wheat IgE sensitization in European
countries is 2.9% (Zuidmeer et al. 2008; Siles and Hsieh 2013). Specific IgE levels higher
than the cut off value (0.10 kU/L or 60 RU) suggests sensitization but are not necessarily
predict clinical symptoms. Such tests can confirm the diagnosis of an allergic disorder,
supplementing a clinical history consistent with an allergic reaction.
We postulate that the remaining 12.8% (n = 125) of individuals who showed raised IgE
antibody levels without symptoms may have a latent wheat sensitivity with the potential of
developing symptoms sooner or later. The large proportion (12.9%) of the investigated
population who have symptoms associated with consumption of wheat products but did
not demonstrate raised IgE may suffer from other wheat related disorders (i.e. not IgE me-
diated) such as celiac disease, non-celiac reaction to gluten or reaction to fructans
(FODMAPS) for those with irritable bowel syndrome.
In contrast to celiac disease, where the toxic epitopes occur only in the prolamins
(mostly in the gliadins but also in the HMW and LMW glutenin subunits), the epitopes re-
sponsible for allergenicity can be found both in the wheat prolamins and soluble proteins
(Juhász et al. 2012).
There has been anecdotic clinical evidence for a long time that a large proportion of
non-celiac patients suffering wheat related health disorders can tolerate products made
from certain spelt varieties. Recently the first research paper with robust experimental and
statistical results also demonstrated this important observation (Armentia et al. 2012). In
our study GWF spelt was found to show significantly less immune reactivity than wheat
and other spelts. It was also found that the albumin-globulin protein composition of GWF
spelt is significantly different from other wheat and wheat related species (Vu 2014). One
of these differences has been identified by comparing the structure of genes coding the al-
lergenic expansin proteins in different wheat and spelt germplasms. The expansin from
GWF spelt has an insertion of three amino acids in the primary sequence and subsequently
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altering the conformation of the entire protein (Breen et al. 2010). This alteration in the
soluble protein composition could be one of the reasons for the significantly lower im-
mune reactivity of GWF spelt. A PCR based procedure, based on the above mutation in
the expansin gene have been developed (Suter and Békés 2012) for screening of any con-
tamination in grain or flour by other cereal with the wild type expansin protein during pos-
sible use for quality assurance purposes.
While these findings do provide some evidence to support the health benefits of this
spelt line, only a clinical trial comparing the allergic symptoms and IgE levels caused by
the consumption of wheat and GWF spelt products, involving both those that eat predomi-
nantly wheat and those who have replaced spelt for wheat in their diet, can answer the
question as to whether our findings are associated with the apparent lower allergenicity of
spelt for those with wheat allergy.
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